| Sequence Name |
Description |
Length |
Blast Hits |
min E-value |
Similarity |
GO hits |
GO names |
Enzyme Codes |
InterPro Scan |
| contig08701 |
---NA--- |
259 |
0 |
|
|
0 |
|
|
|
| contig08702 |
---NA--- |
236 |
0 |
|
|
0 |
|
|
|
| contig08703 |
transmembrane protein 141 |
258 |
20 |
1.06E-27 |
73.40% |
1 |
C:membrane attack complex |
|
|
| contig08704 |
member ras oncogene family |
330 |
20 |
6.52E-38 |
96.95% |
12 |
P:small GTPase mediated signal transduction; P:regulation of transcription, DNA-dependent; C:membrane fraction; C:melanosome; C:ER-Golgi intermediate compartment membrane; P:ER to Golgi vesicle-mediated transport; F:GTPase activity; F:transcription factor binding; P:protein transport; C:endoplasmic reticulum; C:Golgi apparatus; F:GTP binding |
EC:3.6.5.1; EC:3.6.5.2; EC:3.6.5.3; EC:3.6.5.4 |
|
| contig08705 |
glutaminyl-trna synthase (glutamine-hydrolyzing)-like 1 |
1306 |
20 |
6.68E-176 |
82.40% |
2 |
P:translation; F:carbon-nitrogen ligase activity, with glutamine as amido-N-donor |
EC:3.6.5.3; EC:6.3.5.0 |
|
| contig08706 |
sirtuin (silent mating type information regulation 2 homolog) 6 |
238 |
20 |
1.97E-26 |
90.80% |
7 |
F:NAD or NADH binding; F:zinc ion binding; P:protein amino acid deacetylation; C:chromatin silencing complex; F:DNA binding; P:chromatin silencing; F:NAD-dependent histone deacetylase activity |
|
|
| contig08707 |
---NA--- |
248 |
0 |
|
|
0 |
|
|
|
| contig08708 |
hydroxysteroid (17-beta) dehydrogenase 4 |
249 |
20 |
1.88E-21 |
87.70% |
8 |
P:very-long-chain fatty acid metabolic process; P:Sertoli cell development; C:peroxisome; C:mitochondrion; F:3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity; ; F:3-hydroxyacyl-CoA dehydrogenase activity; P:fatty acid beta-oxidation |
EC:4.2.1.107; EC:1.1.1.35 |
|
| contig08709 |
gcn5 general control of amino-acid synthesis 5-like 2 |
260 |
20 |
9.26E-32 |
93.70% |
8 |
P:regulation of transcription from RNA polymerase II promoter; P:protein amino acid acetylation; C:histone acetyltransferase complex; F:histone acetyltransferase activity; F:transcription coactivator activity; P:somitogenesis; F:histone deacetylase binding; P:chromatin remodeling |
EC:2.3.1.48 |
|
| contig08710 |
---NA--- |
276 |
0 |
|
|
0 |
|
|
|
| contig08711 |
---NA--- |
276 |
0 |
|
|
0 |
|
|
|
| contig08712 |
---NA--- |
253 |
0 |
|
|
0 |
|
|
|
| contig08713 |
---NA--- |
263 |
0 |
|
|
0 |
|
|
|
| contig08714 |
---NA--- |
252 |
0 |
|
|
0 |
|
|
|
| contig08715 |
---NA--- |
259 |
0 |
|
|
0 |
|
|
|
| contig08716 |
cyclin i |
241 |
20 |
2.33E-11 |
67.65% |
1 |
P:spermatogenesis |
|
|
| contig08717 |
aquaporin 1 |
419 |
20 |
2.71E-41 |
75.45% |
3 |
P:transport; C:integral to membrane; F:transporter activity |
|
|
| contig08718 |
---NA--- |
257 |
0 |
|
|
0 |
|
|
|
| contig08719 |
zinc dhhc-type containing 3 |
245 |
20 |
2.04E-07 |
96.80% |
14 |
F:transferase activity; P:protein targeting; C:integral to membrane; C:membrane; F:cysteine-type endopeptidase activity; C:Golgi membrane; F:palmitoyltransferase activity; P:protein palmitoylation; C:Golgi apparatus; F:zinc ion binding; P:zinc ion transport; P:proteolysis; F:acyltransferase activity; F:metal ion binding |
|
|
| contig08720 |
---NA--- |
277 |
0 |
|
|
0 |
|
|
|
| contig08721 |
---NA--- |
224 |
0 |
|
|
0 |
|
|
|
| contig08722 |
---NA--- |
244 |
0 |
|
|
0 |
|
|
|
| contig08723 |
loc100101307 protein |
240 |
3 |
6.35E-09 |
83.33% |
0 |
|
|
|
| contig08724 |
---NA--- |
366 |
0 |
|
|
0 |
|
|
|
| contig08725 |
membrane palmitoylated 5 (maguk p55 subfamily member 5) |
244 |
20 |
1.31E-30 |
87.25% |
12 |
P:mesodermal cell migration; P:establishment or maintenance of apical/basal cell polarity; P:cell-cell adhesion; P:establishment or maintenance of polarity of embryonic epithelium; C:tight junction; P:brain development; F:guanylate kinase activity; P:embryonic heart tube development; C:membrane attack complex; F:protein binding; C:photoreceptor inner segment; P:retina development in camera-type eye |
EC:2.7.4.8 |
|
| contig08726 |
---NA--- |
254 |
0 |
|
|
0 |
|
|
|
| contig08727 |
kinesin family member 20a |
276 |
20 |
1.39E-40 |
73.95% |
4 |
C:cytoskeletal part; F:motor activity; F:nucleotide binding; C:microtubule cytoskeleton |
|
|
| contig08728 |
transmembrane emp24 protein transport domain containing 8 |
239 |
20 |
1.32E-30 |
82.55% |
2 |
P:transport; C:integral to membrane |
|
|
| contig08729 |
chromosome 1 open reading frame 52 |
271 |
20 |
3.71E-33 |
80.10% |
2 |
P:P; C:C |
|
|
| contig08730 |
squamous cell carcinoma antigen recognized by t cells 3 isoform 1 |
250 |
20 |
1.82E-32 |
86.10% |
5 |
C:cytoplasm; F:RNA binding; C:nuclear speck; F:nucleotide binding; P:RNA processing |
|
|
| contig08731 |
---NA--- |
294 |
0 |
|
|
0 |
|
|
|
| contig08732 |
synaptic ras gtpase activating protein 1 homolog |
247 |
20 |
9.38E-21 |
90.80% |
62 |
P:negative regulation of transcription, DNA-dependent; C:dendritic shaft; F:protein homodimerization activity; P:negative regulation of axonogenesis; P:protein amino acid glycosylation; P:regulation of long-term neuronal synaptic plasticity; F:steroid binding; F:unfolded protein binding; P:DNA repair; F:protein N-terminus binding; P:androgen receptor signaling pathway; P:immune response; F:transmembrane receptor protein tyrosine kinase activity; C:PML body; P:regulation of synapse structure and activity; P:dendrite development; F:Rab GTPase activator activity; P:phosphate transport; C:actin filament; F:steroid hormone receptor activity; P:valyl-tRNA aminoacylation; C:heterochromatin; F:transcription factor binding; C:extracellular space; F:guanyl-nucleotide exchange factor activity; P:metal ion transport; C:prefoldin complex; C:phagocytic cup; P:visual learning; F:valine-tRNA ligase activity; P:actin filament bundle assembly; ; P:regulation of MAPKKK cascade; P:Ras protein signal transduction; F:extracellular matrix structural constituent; F:androgen receptor binding; C:integral to membrane; F:transcription repressor activity; P:negative regulation of apoptosis; P:cytokinesis after mitosis; F:zinc ion binding; C:Golgi apparatus; P:protein amino acid phosphorylation; F:ATP binding; C:collagen; F:transcription factor activity; C:MHC class I protein complex; P:cell adhesion; P:receptor clustering; C:MHC class II protein complex; F:sequence-specific DNA binding; P:pattern specification process; F:RNA polymerase II transcription factor activity; F:metal ion transmembrane transporter activity; F:calcium ion binding; P:regulation of small GTPase mediated signal transduction; C:membrane fraction; F:tumor necrosis factor receptor binding; P:protein folding; F:ganglioside galactosyltransferase activity; P:antigen processing and presentation of endogenous peptide antigen via MHC class I; C:ruffle |
EC:2.7.10.1; EC:6.1.1.9; EC:2.4.1.62 |
|
| contig08733 |
---NA--- |
253 |
0 |
|
|
0 |
|
|
|
| contig08734 |
---NA--- |
274 |
0 |
|
|
0 |
|
|
|
| contig08735 |
nuclear antigen sp100 |
253 |
20 |
2.09E-15 |
68.70% |
8 |
F:metal ion binding; F:F; F:binding; P:zinc ion transport; P:P; F:zinc ion binding; F:protein binding; C:nucleus |
|
|
| contig08736 |
---NA--- |
267 |
0 |
|
|
0 |
|
|
|
| contig08737 |
glycogen synthase 2 |
257 |
20 |
2.29E-22 |
83.45% |
2 |
P:glycogen biosynthetic process; F:glycogen (starch) synthase activity |
EC:2.4.1.11 |
|
| contig08738 |
---NA--- |
284 |
0 |
|
|
0 |
|
|
|
| contig08739 |
---NA--- |
258 |
0 |
|
|
0 |
|
|
|
| contig08740 |
---NA--- |
254 |
0 |
|
|
0 |
|
|
|
| contig08741 |
st3 beta-galactoside alpha- -sialyltransferase 3 |
244 |
20 |
3.35E-18 |
81.65% |
5 |
C:extracellular space; C:membrane attack complex; P:protein amino acid glycosylation; C:integral to Golgi membrane; F:N-acetyllactosaminide alpha-2,3-sialyltransferase activity |
EC:2.4.99.6 |
|
| contig08742 |
---NA--- |
253 |
0 |
|
|
0 |
|
|
|
| contig08743 |
---NA--- |
240 |
0 |
|
|
0 |
|
|
|
| contig08744 |
---NA--- |
273 |
0 |
|
|
0 |
|
|
|
| contig08745 |
---NA--- |
262 |
0 |
|
|
0 |
|
|
|
| contig08746 |
---NA--- |
252 |
0 |
|
|
0 |
|
|
|
| contig08747 |
---NA--- |
293 |
0 |
|
|
0 |
|
|
|
| contig08748 |
serologically defined colon cancer antigen 1 |
248 |
20 |
6.48E-30 |
91.75% |
2 |
F:F; P:P |
|
|
| contig08749 |
unnamed protein product [Tetraodon nigroviridis] |
244 |
1 |
2.75E-04 |
100.00% |
0 |
|
|
|
| contig08750 |
---NA--- |
300 |
0 |
|
|
0 |
|
|
|
| contig08751 |
protein disulfide isomerase a5 |
244 |
20 |
7.66E-39 |
69.45% |
7 |
C:extracellular space; P:protein folding; C:endoplasmic reticulum lumen; F:electron carrier activity; P:response to stress; F:protein disulfide isomerase activity; F:arsenate reductase (thioredoxin) activity |
EC:5.3.4.1 |
|
| contig08752 |
---NA--- |
239 |
0 |
|
|
0 |
|
|
|
| contig08753 |
---NA--- |
256 |
0 |
|
|
0 |
|
|
|
| contig08754 |
---NA--- |
284 |
0 |
|
|
0 |
|
|
|
| contig08755 |
rna polymerase ii-associated protein 3 |
241 |
3 |
9.47E-13 |
71.67% |
0 |
|
|
|
| contig08756 |
ring finger protein 111 |
244 |
1 |
3.25E-05 |
60.00% |
0 |
|
|
|
| contig08757 |
---NA--- |
243 |
0 |
|
|
0 |
|
|
|
| contig08758 |
im:7145180 protein |
245 |
3 |
1.12E-05 |
76.00% |
7 |
P:integrin-mediated signaling pathway; F:receptor activity; P:cell adhesion; C:integral to membrane; C:integrin complex; C:membrane; F:protein binding |
|
|
| contig08759 |
dna polymerase delta catalytic subunit |
215 |
20 |
3.12E-16 |
97.25% |
5 |
F:DNA-directed DNA polymerase activity; C:nucleus; F:DNA binding; F:nucleotide binding; P:DNA replication |
EC:2.7.7.7 |
|
| contig08760 |
---NA--- |
256 |
0 |
|
|
0 |
|
|
|
| contig08761 |
---NA--- |
268 |
0 |
|
|
0 |
|
|
|
| contig08762 |
---NA--- |
268 |
0 |
|
|
0 |
|
|
|
| contig08763 |
---NA--- |
244 |
0 |
|
|
0 |
|
|
|
| contig08764 |
---NA--- |
238 |
0 |
|
|
0 |
|
|
|
| contig08765 |
zinc finger and at hook domain containing |
243 |
20 |
3.81E-30 |
83.50% |
7 |
F:DNA binding; C:intracellular; P:transport; C:membrane; F:zinc ion binding; P:regulation of transcription, DNA-dependent; F:transporter activity |
|
|
| contig08766 |
---NA--- |
283 |
0 |
|
|
0 |
|
|
|
| contig08767 |
zinc dhhc domain containing 2 |
240 |
20 |
1.83E-32 |
93.75% |
5 |
F:palmitoyltransferase activity; P:zinc ion transport; C:integral to membrane; P:protein palmitoylation; F:zinc ion binding |
|
|
| contig08768 |
coagulation factor ix |
248 |
20 |
9.01E-40 |
69.90% |
3 |
P:blood coagulation; F:coagulation factor IXa activity; C:extracellular region |
EC:3.4.21.22 |
|
| contig08769 |
---NA--- |
263 |
0 |
|
|
0 |
|
|
|
| contig08770 |
---NA--- |
210 |
0 |
|
|
0 |
|
|
|
| contig08771 |
---NA--- |
245 |
0 |
|
|
0 |
|
|
|
| contig08772 |
smith-magenis syndrome chromosome candidate 7-like |
305 |
20 |
2.92E-38 |
73.20% |
3 |
F:F; C:membrane; C:C |
|
|
| contig08773 |
novel protein vertebrate protein phosphatase 2 (formerly 2a) regulatory subunit b family |
248 |
17 |
5.51E-13 |
72.82% |
9 |
F:protein serine/threonine phosphatase activity; C:nucleus; P:protein amino acid dephosphorylation; C:protein phosphatase type 2A complex; F:protein phosphatase type 2A regulator activity; F:protein binding; F:calcium ion binding; P:DNA replication initiation; P:cell cycle arrest |
|
|
| contig08774 |
---NA--- |
183 |
0 |
|
|
0 |
|
|
|
| contig08775 |
udp-n-acetyl-alpha-d-galactosamine:polypeptide n-acetylgalactosaminyltransferase 6 |
248 |
20 |
2.45E-37 |
90.30% |
11 |
P:protein amino acid O-linked glycosylation; F:calcium ion binding; F:calcium channel inhibitor activity; F:manganese ion binding; C:Golgi membrane; F:calcium channel activity; F:polypeptide N-acetylgalactosaminyltransferase activity; C:membrane attack complex; P:calcium ion transport; C:perinuclear region of cytoplasm; F:sugar binding |
EC:2.4.1.41 |
|
| contig08776 |
---NA--- |
260 |
0 |
|
|
0 |
|
|
|
| contig08777 |
tbc1 domain member 24 |
261 |
20 |
2.68E-39 |
78.25% |
1 |
F:GTPase activator activity |
|
|
| contig08778 |
---NA--- |
248 |
0 |
|
|
0 |
|
|
|
| contig08779 |
---NA--- |
252 |
0 |
|
|
0 |
|
|
|
| contig08780 |
fanconi complementation group b |
247 |
12 |
5.52E-05 |
56.25% |
2 |
P:DNA repair; C:nucleus |
|
|
| contig08781 |
---NA--- |
251 |
0 |
|
|
0 |
|
|
|
| contig08782 |
---NA--- |
270 |
0 |
|
|
0 |
|
|
|
| contig08783 |
dna helicase hel308 |
265 |
18 |
1.58E-07 |
83.17% |
8 |
P:DNA metabolic process; F:helicase activity; F:nucleic acid binding; C:single-stranded DNA-dependent ATP-dependent DNA helicase complex; F:ATP binding; F:single-stranded DNA-dependent ATP-dependent DNA helicase activity; F:hydrolase activity; F:ATP-dependent helicase activity |
|
|
| contig08784 |
slc26a6 a |
215 |
4 |
2.65E-07 |
80.75% |
0 |
|
|
|
| contig08785 |
---NA--- |
243 |
0 |
|
|
0 |
|
|
|
| contig08786 |
---NA--- |
243 |
0 |
|
|
0 |
|
|
|
| contig08787 |
rest corepressor 3 |
240 |
20 |
3.36E-18 |
70.95% |
3 |
P:transcription; C:nucleus; F:DNA binding |
|
|
| contig08788 |
---NA--- |
277 |
0 |
|
|
0 |
|
|
|
| contig08789 |
---NA--- |
252 |
0 |
|
|
0 |
|
|
|
| contig08790 |
novel protein |
271 |
2 |
2.26E-06 |
71.50% |
0 |
|
|
|
| contig08791 |
---NA--- |
255 |
0 |
|
|
0 |
|
|
|
| contig08792 |
---NA--- |
256 |
0 |
|
|
0 |
|
|
|
| contig08793 |
---NA--- |
260 |
0 |
|
|
0 |
|
|
|
| contig08794 |
---NA--- |
267 |
0 |
|
|
0 |
|
|
|
| contig08795 |
spectrin repeat nuclear envelope 2 |
283 |
20 |
7.16E-13 |
88.20% |
5 |
C:integral to membrane; C:cytoplasm; F:actin binding; F:structural molecule activity; C:nuclear membrane |
|
|
| contig08796 |
---NA--- |
229 |
0 |
|
|
0 |
|
|
|
| contig08797 |
ras homolog enriched in brain |
255 |
20 |
1.94E-21 |
96.00% |
8 |
F:GTP binding; P:regulation of neuronal synaptic plasticity; C:plasma membrane; C:spliceosomal complex; F:protein binding; P:small GTPase mediated signal transduction; F:GDP binding; F:GTPase activity |
EC:3.6.5.1; EC:3.6.5.2; EC:3.6.5.3; EC:3.6.5.4 |
|
| contig08798 |
---NA--- |
270 |
0 |
|
|
0 |
|
|
|
| contig08799 |
---NA--- |
240 |
0 |
|
|
0 |
|
|
|
| contig08800 |
---NA--- |
268 |
0 |
|
|
0 |
|
|
|
100 Rows returned.
Helpdesk 